[ad_1]
MANILA, Philippines – US pharmaceutical company Pfizer submitted its application for an emergency use authorization (USA) of its COVID-19 vaccine in the Philippines, Malacañang said on Saturday.
Presidential spokesman Harry Roque said that the Director General of the Food and Drug Administration (FDA), Rolando Domingo, during a meeting in Malacañang with President Duterte and several members of the Cabinet, confirmed that Pfizer was presented to the US on 23 February. December.
“It will take the FDA 21 days to evaluate and approve the EUA, but vaccination will begin as soon as stocks are available,” Roque said in a statement.
Obtaining an EUA from the Philippine regulator will allow a new vaccine to be administered in the country.
The FDA previously said that applicants must first submit the USA from the regulatory agency in their home country before applying in the Philippines. The FDA will use the available data in its evaluation.
Pfizer has already obtained an EUA for the US FDA.
[ac]
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare leaders and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
